IOM drug forum explores challenges of genomics-based medicine

    loading  Checking for direct PDF access through Ovid

Abstract

▪ The first of three meetings convened by the US Institute of Medicine looked at genomics-based, targeted therapies, and the genetic basis of adverse events.

Related Topics

    loading  Loading Related Articles